MiR-675 mediates downregulation of twist1 and rb in afp-secreting hepatocellular carcinoma

Annals of Surgical Oncology

Volumn 20, Issue 3 SUPPL., 2013, Pages

  Hernandez, J M ^a   Elahi, A ^a   Clark, C W ^a   Wang, J ^a   Humphries, L A ^a   Centeno, B ^a   Bloom, G ^a   Fuchs, B C ^b,c   Yeatman, T ^a   Shibata, D ^a  

^a H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL CANCER CENTER   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA FETOPROTEIN; ANTAGOMIR; MICRORNA; MICRORNA 675; RETINOBLASTOMA PROTEIN; RNA H19; TRANSCRIPTION FACTOR TWIST; TRANSCRIPTION FACTOR TWIST1; UNCLASSIFIED DRUG; AFP PROTEIN, HUMAN; LUCIFERASE; MESSENGER RNA; MIRN675 MICRORNA, HUMAN; NUCLEAR PROTEIN; TUMOR MARKER; TWIST1 PROTEIN, HUMAN;

ADULT; AGED; ALPHA FETOPROTEIN BLOOD LEVEL; ALPHA FETOPROTEIN SECRETING HEPATOCELLULAR CARCINOMAS; ANCHORAGE INDEPENDENT GROWTH; ARTICLE; CELL ADHESION; CELL CYCLE ASSAY; CELL FUNCTION; CELL GROWTH ASSAY; CELL INVASION ASSAY; CELL PROLIFERATION ASSAY; CLINICAL ARTICLE; DNA CONTENT; DOWN REGULATION; FEMALE; GENE OVEREXPRESSION; GENE SILENCING; HEPATOMA CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; LIVER CELL CARCINOMA; MALE; MIDDLE AGED; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION; APOPTOSIS; CANCER GRADING; CANCER STAGING; CELL MOTION; CELL PROLIFERATION; DNA MICROARRAY; EPITHELIAL MESENCHYMAL TRANSITION; GENE EXPRESSION PROFILING; GENETICS; LIVER TUMOR; METABOLISM; PATHOLOGY; PROGNOSIS; REAL TIME POLYMERASE CHAIN REACTION; SECRETION (PROCESS); SURVIVAL RATE; TUMOR CELL CULTURE; WESTERN BLOTTING;

AGED; ALPHA-FETOPROTEINS; APOPTOSIS; BLOTTING, WESTERN; CARCINOMA, HEPATOCELLULAR; CELL ADHESION; CELL MOVEMENT; CELL PROLIFERATION; EPITHELIAL-MESENCHYMAL TRANSITION; FEMALE; GENE EXPRESSION PROFILING; HUMANS; LIVER NEOPLASMS; LUCIFERASES; MALE; MICRORNAS; MIDDLE AGED; NEOPLASM GRADING; NEOPLASM STAGING; NUCLEAR PROTEINS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROGNOSIS; REAL-TIME POLYMERASE CHAIN REACTION; RETINOBLASTOMA PROTEIN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SURVIVAL RATE; TUMOR CELLS, CULTURED; TUMOR MARKERS, BIOLOGICAL; TWIST TRANSCRIPTION FACTOR;

EID: 84892815362     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-013-3106-3     Document Type: Article

References (40)

1. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, et al. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 2010;127:2893-7.
2. Benson AB, 3rd, Abrams TA, Ben-Josef E, Bloomston PM, Botha JF, et al. NCCN clinical practice guidelines in oncology: hepatobiliary cancers. J Natl Compr Cancer Netw. 2009;7: 350-91.
3. Tangkijvanich P, Anukulkarnkusol N, Suwangool P, Lertmaharit S, Hanvivatvong O, et al. Clinical characteristics and prognosis of hepatocellular carcinoma: analysis based on serum alpha-fetoprotein levels. J Clin Gastroenterol. 2000;31:302-8.
4. Hoshida Y, Nijman SM, Kobayashi M, Chan JA, Brunet JP, et al. Integrative transcriptome analysis reveals common molecular subclasses of human hepatocellular carcinoma. Cancer Res. 2009;69:7385-92.
5. Takayasu K, Arii S, Ikai I, Omata M, Okita K, et al. Prospective cohort study of transarterial chemoembolization for unresectable hepatocellular carcinoma in 8510 patients. Gastroenterology 2006;131:461-9.
6. Taketa K Alpha-fetoprotein: reevaluation in hepatology. Hepatology 1990;12:1420-32.
7. Budhu A, Forgues M, Ye QH, Jia HL, He P, et al. Prediction of venous metastases, recurrence, and prognosis in hepatocellular carcinoma based on a unique immune response signature of the liver microenvironment. Cancer Cell 2006;10:99-111.
8. Lee JS, Heo J, Libbrecht L, Chu IS, Kaposi-Novak P, et al. A novel prognostic subtype of human hepatocellular carcinoma derived from hepatic progenitor cells. Nat Med. 2006;12:410-6.
9. Wurmbach E, Chen YB, Khitrov G, Zhang W, Roayaie S, et al. Genome-wide molecular profiles of HCV-induced dysplasia and hepatocellular carcinoma. Hepatology 2007;45:938-47.
10. Dudich E, Semenkova L, Gorbatova E, Dudich I, Khromykh L, et al. Growth-regulative activity of human alpha-fetoprotein for different types of tumor and normal cells. Tumour Biol. 1998;19:30-40.
11. Li MS, Li PF, Yang FY, He SP, Du GG, et al. The intracellular mechanism of alpha-fetoprotein promoting the proliferation of NIH 3T3 cells. Cell Res. 2002;12:151-6.
12. Wang XW, Xu B Stimulation of tumor-cell growth by alphafetoprotein. Int J Cancer 1998;75:596-9.
13. Fuchs BC, Fujii T, Dorfman JD, Goodwin JM, Zhu AX, et al. Epithelial-to-mesenchymal transition and integrin-linked kinase mediate sensitivity to epidermal growth factor receptor inhibition in human hepatoma cells. Cancer Res. 2008;68:2391-9.
14. Irizarry RA, Hobbs B, Collin F, Beazer-Barclay YD, Antonellis KJ, et al. Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics 2003;4:249-64.
15. Elahi A, Zhang L, Yeatman TJ, Gery S, Sebti S, et al. HPP1- mediated tumor suppression requires activation of STAT1 pathways. Int J Cancer 2008;122:1567-72.
16. Tsang WP, Ng EK, Ng SS, Jin H, Yu J, et al. Oncofetal H19- derived miR-675 regulates tumor suppressor RB in human colorectal cancer. Carcinogenesis 2010;31:350-8.
17. Yoshimizu T, Miroglio A, Ripoche MA, Gabory A, Vernucci M, et al. The H19 locus acts in vivo as a tumor suppressor. Proc Natl Acad Sci USA 2008;105:12417-22.
18. Berteaux N, Lottin S, Monte D, Pinte S, Quatannens B, et al. H19 mRNA-like noncoding RNA promotes breast cancer cell proliferation through positive control by E2F1. J Biol Chem. 2005;280:29625-36.
19. Matouk IJ, Mezan S, Mizrahi A, Ohana P, Abu-Lail R, et al. The oncofetal H19 RNA connection: hypoxia, p53 and cancer. Biochim Biophys Acta 2010;1803:443-51.
20. Gentric G, Desdouets C, Celton-Morizur S Hepatocytes polyploidization and cell cycle control in liver physiopathology. Int J Hepatol. 2012;28:2430.
21. Margolis RL Tetraploidy and tumor development. Cancer Cell 2005;8:353-4.
22. Gabory A, Jammes H, Dandolo L The H19 locus: role of an imprinted non-coding RNA in growth and development. Bioessays 2010;32:473-80.
23. Wu J, Qin Y, Li B, He WZ, Sun ZL Hypomethylated and hypermethylated profiles of H19DMR are associated with the aberrant imprinting of IGF2 and H19 in human hepatocellular carcinoma. Genomics 2008;91:443-50.
24. Li J, Ran C, Li E, Gordon F, Comstock G, et al. Synergistic function of E2F7 and E2F8 is essential for cell survival and embryonic development. Dev Cell 2008;14:62-75.
25. Lottin S, Adriaenssens E, Dupressoir T, Berteaux N, Montpellier C, et al. Overexpression of an ectopic H19 gene enhances the tumorigenic properties of breast cancer cells. Carcinogenesis 2002;23:1885-95.
26. Kruger J, Rehmsmeier M RNAhybrid: microRNA target prediction easy, fast and flexible. Nucl Acids Res. 2006;34: W451-4.
27. Baum B, Settleman J, Quinlan MP Transitions between epithelial and mesenchymal states in development and disease. Semin Cell Dev Biol. 2008;19:294-308.
28. Thiery JP, Sleeman JP Complex networks orchestrate epithelial- mesenchymal transitions. Nat Rev Mol Cell Biol. 2006;7: 131-42.
29. Lee TK, Poon RT, Yuen AP, Ling MT, Kwok WK, et al. Twist overexpression correlates with hepatocellular carcinoma metastasis through induction of epithelial-mesenchymal transition. Clin Cancer Res. 2006;12:5369-76.
30. Matsuo N, Shiraha H, Fujikawa T, Takaoka N, Ueda N, et al. Twist expression promotes migration and invasion in hepatocellular carcinoma. BMC Cancer 2009;9:240.
31. Gunasinghe NP, Wells A, Thompson EW, Hugo HJ Mesenchymal- epithelial transition (MET) as a mechanism for metastatic colonisation in breast cancer. Cancer Metastasis Rev. 2012; 31:469-78.
32. Lustig-Yariv O, Schulze E, Komitowski D, Erdmann V, Schneider T, et al. The expression of the imprinted genes H19 and IGF-2 in choriocarcinoma cell lines. Is H19 a tumor suppressor gene? Oncogene 1997;15:169-77.
33. Rachmilewitz J, Elkin M, Rosensaft J, Gelman-Kohan Z, Ariel I, et al. H19 expression and tumorigenicity of choriocarcinoma derived cell lines. Oncogene 1995;11:863-70.
34. Yang J, Mani SA, Donaher JL, Ramaswamy S, Itzykson RA, et al. Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis. Cell 2004;117:927-39.
35. Yang MH, Chen CL, Chau GY, Chiou SH, Su CW, et al. Comprehensive analysis of the independent effect of twist and snail in promoting metastasis of hepatocellular carcinoma. Hepatology 2009;50:1464-74.
36. Hugo H, Ackland ML, Blick T, Lawrence MG, Clements JA, et al. Epithelial-mesenchymal and mesenchymal-epithelial transitions in carcinoma progression. J Cell Physiol. 2007;213: 374-83.
37. Yang J, Weinberg RA Epithelial-mesenchymal transition: at the crossroads of development and tumor metastasis. Dev Cell 2008;14:818-29.
38. Mani SA, Guo W, Liao MJ, Eaton EN, Ayyanan A, et al. The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 2008;133:704-15.
39. Morel AP, Lievre M, Thomas C, Hinkal G, Ansieau S, et al. Generation of breast cancer stem cells through epithelial-mesenchymal transition. PLoS One 2008;3:e2888.
40. Peinado H, Olmeda D, Cano A Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype? Nat Rev Cancer 2007;7:415-28.